Trials / Completed
CompletedNCT02456480
Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Study to Assess the Pharmacodynamics, Safety/Tolerability and Efficacy of Omiganan in Patients With Mild to Moderate Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To assess the pharmacodynamics, safety/tolerability, and efficacy of omiganan in patients with mild to moderate atopic dermatitis (AD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CLS001 | topical gel |
| DRUG | Vehicle | topical gel |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-05-28
- Last updated
- 2016-07-28
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02456480. Inclusion in this directory is not an endorsement.